Stephan Ariyan
Overview
Explore the profile of Stephan Ariyan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
2419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frey A, Kerekes D, Khan S, Tran T, Kluger H, Clune J, et al.
Front Oncol
. 2024 Feb;
14:1336441.
PMID: 38380358
Background: Immunotherapy agents are approved for adjuvant treatment of stage III melanoma; however, evidence for survival benefit in early stage III disease is lacking. Current guidelines for adjuvant immunotherapy utilization...
2.
Rusheen J, Clune J, Ariyan S, Baumann R, Kluger H, Olino K, et al.
Front Oncol
. 2023 Jul;
13:1217816.
PMID: 37476373
Merkel cell carcinoma (MCC) is a rare tumor with a high risk of recurrence after definitive therapy; however, the optimal duration of surveillance is unclear. First recurrences typically occur within...
3.
Papageorge M, Maina R, King A, Lee V, Baumann R, Pucar D, et al.
Front Oncol
. 2023 May;
13:1143354.
PMID: 37223678
Background: Previous studies demonstrate minimal utility of pre-operative imaging for low-risk melanoma; however, imaging may be more critical for patients with high-risk disease. Our study evaluates the impact of peri-operative...
4.
Sasson D, Smetona J, Parsaei Y, Papageorge M, Ariyan S, Olino K, et al.
Cureus
. 2023 Mar;
15(2):e34742.
PMID: 36909026
Objective In this study, we aimed to compare the clinical outcomes between older and younger patients with melanoma and to evaluate for differences in tumor genetic makeup that might explain...
5.
Ly C, Blaha O, Wei W, Galan A, Kluger H, Ariyan S, et al.
Front Oncol
. 2023 Jan;
12:1077226.
PMID: 36686728
Background: Mitotic rate (MR) is considered an important prognostic factor for melanoma but is not currently used for staging because its nuanced effect is not yet well-delineated. We sought to...
6.
Farshidfar F, Rhrissorrakrai K, Levovitz C, Peng C, Knight J, Bacchiocchi A, et al.
Nat Commun
. 2022 May;
13(1):2704.
PMID: 35538087
No abstract available.
7.
Farshidfar F, Rhrissorrakrai K, Levovitz C, Peng C, Knight J, Bacchiocchi A, et al.
Nat Commun
. 2022 Feb;
13(1):898.
PMID: 35197475
Acral melanoma, the most common melanoma subtype among non-White individuals, is associated with poor prognosis. However, its key molecular drivers remain obscure. Here, we perform integrative genomic and clinical profiling...
8.
Noorbakhsh S, Papageorge M, Maina R, Baumann R, Moores C, Weiss S, et al.
Plast Reconstr Surg Glob Open
. 2021 Dec;
9(12):e4004.
PMID: 34938645
Methods: A retrospective review of a prospectively maintained database evaluated 80 patients with auricular melanoma who underwent sentinel lymph node biopsy by comparing preoperative imaging with intraoperative identification of sentinel...
9.
Esposito A, Jacobs D, Ariyan S, Galan A, Kluger H, Clune J, et al.
Ann Surg Oncol
. 2021 Sep;
29(1):415-424.
PMID: 34494169
Background: Merkel cell carcinoma (MCC) is an aggressive neuroendocrine carcinoma of the skin. Our report describes the evolution of management and characteristics associated with recurrence, disease-specific survival (DSS) and overall...
10.
Walker M, Han G, Gabrick K, Kanouzi J, Lo Y, Galan A, et al.
Plast Reconstr Surg Glob Open
. 2020 Jun;
8(3):e2698.
PMID: 32537354
Methods: Patients with localized ALM diagnosed from 1982 to 2017 were retrospectively identified. Clinicopathologic characteristics were correlated with surgical approach, nodal metastasis, overall survival, and recurrence-free survival. Results: There were...